Kruppel-like Factor 4 Is a Novel Mediator of Kallistatin in Inhibiting Endothelial Inflammation via Increased Endothelial Nitric-oxide Synthase Expression-Reference-Cited by-同舟云学术

Kruppel-like Factor 4 Is a Novel Mediator of Kallistatin in Inhibiting Endothelial Inflammation via Increased Endothelial Nitric-oxide Synthase Expression

Published:2009-12 Issue:51 Volume:284 Page:35471-35478
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Shen Bo,Smith Robert S.,Hsu Yi-Te,Chao Lee,Chao Julie

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference42 articles.

1. Identification of a new tissue-kallikrein-binding protein

2. Kallistatin: a novel human serine proteinase inhibitor. Molecular cloning, tissue distribution, and expression in Escherichia coli.

3. Kallistatin is a potent new vasodilator.

4. Kallistatin is a new inhibitor of angiogenesis and tumor growth

5. Structural elements of kallistatin required for inhibition of angiogenesis

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovering the Radiation Biomarkers in the Plasma of Total-Body Irradiated Leukemia Patients;Radiation Research;2024-05-08

2. Protective role of kallistatin in oxygen-glucose deprivation and reoxygenation in human umbilical vein endothelial cells;Clinical and Experimental Emergency Medicine;2024-03-21

3. Functional omics of ORP7 in primary endothelial cells;2024-03-19

4. Kallistatin deficiency exacerbates neuronal damage after cardiac arrest;Scientific Reports;2024-02-21

5. KLF4 down-regulation underlies placental angiogenesis impairment induced by maternal glucose intolerance in late pregnancy;The Journal of Nutritional Biochemistry;2024-02